Novel Compound That Engages ‘Second Arm’ of Immune System Reduces Breast Tumors and Metastases, Study Shows
Dana-Farber Cancer InstituteIn a new study in the journal Nature, Dana-Farber Cancer Institute scientists report that a compound able to reverse the allegiance of innate immune system cells – turning them from tumor enablers into tumor opponents – caused breast tumors in mice to shrink and withdraw from distant metastases.